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OL-024 Genetic diversity and nucleoside analogues
resistance mutations of hepatitis B virus in
Russian Federation and Viet Nam
E.A. Elpaeva1, A.B. Komissarov1, E.A. Poretskova1,
O.P. Dudanova2, D.T. Tuyeˆn3, M.M. Pisareva1,
E.V. Esaulenko1 *, M.P. Grudinin1. 1Research Institute of
Inﬂuenza, Russian Academy of Medical Science, Saint
Petersburg, Russia, 2Petrozavodsk State University,
Petrozavodsk, Russia, 3Military Institute of Hygiene and
Epidemiology, Hanoi, Vietnam
Objectives: To reveal HBV genetic diversity in chronic
hepatitis patients from 4 regions of Russia, to determine
the structure of HBVDNA polymerase gene fragments
responsible for nucleoside analogues treatment.
Methods: HBV genotyping by original PCR method.
Sequencing of polymerase gene fragment. Real time PCR
to determine viral load in patients’ blood and liver biopsy.
Disease severity evaluated by clinical-laboratory markers
and morphology.
Results: In 2008 2010 HBV genotypes were determined in
381 patients with chronic hepatitis B from Saint Petersburg
region, Karelia (Petrozavodsk), 2 districts from Central part
of Russia (Perm and Kazan) and Vietnam. HBV D genotype
was revealed in 77% of cases in Saint Petersburg region,
86% in Petrozavodsk, 67% in Perm and 83% in Kasan. In the
rest of cases A genotype was determined in these regions.
In Vietnam samples two HBV genotypes were detected:
genotype B 86% and C 14% of cases. As reported
previously more severe disease was diagnosed in Russian
patients with HBV A genotype. 98% of patients with HBV D
genotype were HBeAg-negative.
HBV polymerase gene fragment sequencing from 62 patients
revealed high diversity of this fragment. YMDD-motif in
all cases was characteristic for wild type (lamivudin
susceptible). Russian patients have been successfully
treated by talbivudine during 1 year in the absence
of resistance mutations. However, lamivudin/adefovir
resistance mutation rtA181T and entecavir resistant
mutation rtS202N were revealed in 3 and 4 sequences from
Vietnam patients, correspondingly. Interestingly that the
entecavir resistance mutation was observed in patients not
treated with entecavir.
Conclusion: Comparing with the period of 2004 2008
HBV genotypes distribution in Saint Petersburg region in
2008 2010 considerably changed as the result of active
migration of population from Central Russia. HBV sequencing
analyses obtained in this study allowed to justify the therapy
selection.
OL-025 Research on the immunological mechanism
of one new type adjuvant for therapeutic
hepatitis B vaccine
P. He1 *, X.C. Zhang1, Z.Y. Hu1, X. Fang1, S.H. Qiu1,
Z.L. Liang1. 1National Institute for the Control of
Pharmaceutical and Biological Products, China
Background: Recently, studies showed that bacterial
DNA and synthetic non-methylated CpG containing
Oligonucleotide (CpG-ODN) can stimulate the immune
response, promoting the proliferation and differentiation
of immune cells. Hepatitis B vaccines with CpG as adjuvant
are under phase II clinical studies abroad. At present, studies
on CpG-ODN mainly focused on humoral immune responses.
In this paper, study on the cellular immunology of a new
type CpG-ODN (BW006) was carried out.
Methods: Spleen MNCs of BALB/c mice were separated
aseptically and added into cell culture plates accompanied
by BW006 after cell concentrations were adjusted. Plates
were incubated under 37ºC for different time. Expression
levels of mRNA of IL-12p35, IL-12p40 and IFN-g inducing
protein (IP-10) in MNCs were detected by bDNA kit from
Panomics. Expression level of IL-12 was detected by Luminex
100TM analyzer. Level of IP-10 in peripheral blood of BALB/c
mice inoculated subcutaneously with 200 mg BW006 was
detected with IP-10 detection kit (R&D) 3 hours after
inoculation.
Result: Three hours after stimulation with BW006, IL-12p35
and IP-10 mRNA levels increased by 2.2 times and 2.8 times,
respectively; 6 hours after stimulation, IL-12p40 mRNA level
increased by 26 times. Expression of IL-12 reached peak
level 48 hours after stimulation (9198.71pg/ml). IP-10 level
of mice inoculated with BW006 was signiﬁcantly higher
than that of control group (14001.31pg/ml, 300.78 pg/ml;
P< 0.01).
Conclusion: BW006 can induce high level expressions of
IL-12 and IP-10 both at transcriptional and translational
levels in early phase after in vitro stimulation. Elevated
levels of IL-12 and IP-10 in mice after stimulation with
BW006 implies that BW006 has strong ability in inducing
Th1 type cellular immune response, which provides new
clues for the development of new therapeutic hepatitis B
vaccines.
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PL-006 Myeloid-derived suppressor cells act as a key
immune regulator in the CSF of patients with
bacterial meningitis post-neurosurgery
G.Z. Shi1, J.Y. Han2,3 *, G. Liu4, Y. Hao2,3, B.B. Wang2,3,
Y.A. Liu5, Y. Mao2,3, J.Z. Zhao6, J.X. Zhou1, H. Zeng2,3.
1Intensive Care Unit, Beijing Tiantan Hospital, China
Capital Medical University, 2Institute of Infectious diseases,
China Capital Medical University, 3Institute of Infectious
diseases, Beijing Ditan Hospital, 4Department of infectious
diseases, Beijing Children’s Hospital, China Capital Medical
University, Beijing, 5Department of Laboratory Medicine,
Beijing Tiantan Hospital, China Capital Medical University,
6Department of Neurosurgery, Beijing Tiantan Hospital,
China Capital Medical University, China
Bacterial meningitis is one of the common and serious
complications after neurosurgery. In bacterial meningitis,
peripheral blood leukocytes migrate into CSF through a
series of cytokines and chemokines, and then regulate
the local inﬂammation responses. On the other hand,
compensatory anti-inﬂammatory mechanisms are necessary
to avoid excessive inﬂammatory responses. Regulatory T
cells (Tregs) and myeloid-derived suppressor cells (MDSCs)
have been considered two major immune suppressive cells.
We therefore investigated whether Tregs and MDSCs could be
involved in immune responses in adult bacterial meningitis
post-neurosurgery. In our study, we found the frequencies
of Tregs and MDSCs elevated within the CSF compared with
that in peripheral blood in patients with bacterial meningitis
post-neurosurgery. MDSCs in CSF consisted of immature
granulocytes mainly, which were capable of exerting a T
cell suppressive effect in vitro. Furthermore, they could
also induced resting Treg (rTreg) to activated Treg (aTreg).
In the migration assay, rather than Treg-speciﬁc, but MDSC-
speciﬁc chemotactic activity increased in CSF supernatants.
In conclusion, both Tregs and MDSCs, especially MDSCs,
should play important roles in bacterial meningitis as
negative regulatory cells. And MDSCs would migrate into
the CSF along a series of cytokines and chemokines. These
